- Home
- TPST vs CPIX Comparison
TPST vs CPIX Comparison
Compare TPST & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- CPIX
- Stock Information
- Founded
- TPST 2011
- CPIX 1999
- Country
- TPST United States
- CPIX United States
- Employees
- TPST N/A
- CPIX N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- TPST Health Care
- CPIX Health Care
- Exchange
- TPST Nasdaq
- CPIX Nasdaq
- Market Cap
- TPST 45.5M
- CPIX 51.5M
- IPO Year
- TPST N/A
- CPIX 2009
- Fundamental
- Price
- TPST $10.45
- CPIX $3.48
- Analyst Decision
- TPST Hold
- CPIX
- Analyst Count
- TPST 3
- CPIX 0
- Target Price
- TPST $30.00
- CPIX N/A
- AVG Volume (30 Days)
- TPST 47.7K
- CPIX 30.4K
- Earning Date
- TPST 11-11-2025
- CPIX 11-04-2025
- Dividend Yield
- TPST N/A
- CPIX N/A
- EPS Growth
- TPST N/A
- CPIX N/A
- EPS
- TPST N/A
- CPIX N/A
- Revenue
- TPST N/A
- CPIX $42,071,813.00
- Revenue This Year
- TPST N/A
- CPIX N/A
- Revenue Next Year
- TPST N/A
- CPIX N/A
- P/E Ratio
- TPST N/A
- CPIX N/A
- Revenue Growth
- TPST N/A
- CPIX 11.34
- 52 Week Low
- TPST $5.35
- CPIX $1.04
- 52 Week High
- TPST $15.73
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- TPST 49.98
- CPIX 53.37
- Support Level
- TPST $10.09
- CPIX $3.41
- Resistance Level
- TPST $10.79
- CPIX $3.68
- Average True Range (ATR)
- TPST 0.68
- CPIX 0.21
- MACD
- TPST -0.11
- CPIX 0.01
- Stochastic Oscillator
- TPST 16.93
- CPIX 65.00
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.